VR program to improve focus during homework for emerging adults with ADHD
Official title: Development of a Novel Virtual Reality Treatment for Emerging Adults With ADHD
Run by Rutgers, The State University of New Jersey · NCT07169760 · Data updated 2026-11-12
This trial will test whether using a virtual reality headset, with or without real-time feedback about focus, helps 18–25-year-olds with ADHD stay focused while doing homework and studying.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 25 Years |
| Sex | All |
| Enrollment | 252 (estimated) |
| Sponsor | Rutgers, The State University of New Jersey Academic / other |
| Locations | 2 sites (Baton Rouge, Louisiana and 1 other locations) |
| Status | Recruiting |
| Started | September 9, 2025 |
| Main results expected | September 2030 |
| Study ends | December 2030 |
| Registry record updated | January 28, 2026 |
| Trial ID | NCT07169760 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are 18–25-year-olds who meet DSM-5 criteria for ADHD and report frequent homework concentration problems (ACI item mean >2.0) and can complete remote VR sessions.
✕Probably not a fit
Patients outside the 18–25 age range, those without significant homework concentration problems, or individuals unable to tolerate or use VR headsets (e.g., severe motion sickness or incompatible visual impairments) may not receive benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a multi-site, parallel-group randomized trial that will assign emerging adults with ADHD (ages 18–25) to one of three conditions: VR passthrough control, VR headset alone, or VR headset with feedback about focus, using a 1:1:1 blocked randomization stratified by ADHD medication status. After a two-session baseline without VR, participants will receive a Meta Quest 3 headset and computer and complete up to ten 1-hour at-home VR study/homework sessions over two weeks. Outcomes include self-reported concentration, homework effort and motivation, and objective keyboard and mouse click data to measure productivity; proposed mechanisms are measured every session. Phase 4 increases sample size to approximately 252 randomized participants to provide more precise estimates of feasibility, usability, and preliminary effects.
Why it matters
Potential benefit: If successful, the program could help emerging adults with ADHD improve concentration and homework productivity, making studying more efficient and less frustrating.
How similar studies have gone: Early pilot studies and smaller trials suggest VR can increase engagement and attention in related populations, but large randomized trials in emerging adults with ADHD remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants must meet DSM-5 criteria for ADHD * Between the ages of 18 and 25 * Given high rates of comorbidities in college students with ADHD, participants who meet criteria for ODD, anxiety or depressive disorders on the diagnostic interview are not excluded * Participants must have an item mean score of \>2.0 (often or very often) on the homework task specific version of the Adult Concentration Index (ACI), ensuring the presence of a problem in the mechanism being targeted in this study * The participant has to endorse a total of at least 5 symptoms in the ADHD inattention domain as currently present and impairing and at least 6 symptoms in the ADHD inattention domain as present and impairing during childhood * To rule out exclusionary conditions and/or to assess for the presence of comorbid conditions, psychological functioning will be assessed using the DSM-5 version of the Structured Clinical Interview for DSM Disorders (SCID-5-RV) Exclusion Criteria: * Whether primary or not, the comorbid presence of several other conditions will be exclusionary.This includes autism spectrum disorders, bipolar disorder, obsessive-compulsive disorder, active substance abuse, and other psychiatric conditions whose treatment precludes participation in the study. * Students who do not meet criteria for ADHD are not eligible * Students who are not in the specified age range are also not eligible to participate * Students with a history of seizures are not eligible to participate given the use of VR
Where it's running
-
Louisiana State University
Baton Rouge, Louisiana, United States Recruiting -
Rutgers University - New Brunswick
New Brunswick, New Jersey, United States Recruiting
Study contacts
- Principal investigator: Joshua M Langberg, PhD — Rutgers University
- Study coordinator: Joshua M Langberg, PhD
- Email: jl3079@gsapp.rutgers.edu
- Phone: (848) 445-2000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Foquest in older adults with ADHD: daily methylphenidate for 65+
This study tests whether once-daily Foquest helps symptoms in adults 65 and older with ADHD.
-
Neuroplasticity-targeted supplements for ADHD in children
A 12-week randomized trial tests whether gut- and brain-targeted supplements can help reduce ADHD symptoms in children aged 6–12.
-
Therapy approaches for irritability in youths: active treatments vs nonactive psychoeducation
This study tests whether active psychotherapies for irritability in kids aged 8–16.5 years work better than nonactive, time-matched psychoeducation for children and their parents.
-
Playful physiotherapy to support children with ADHD or autism
This program will try a play-based physiotherapy approach to see if it improves emotional, behavioral, and social functioning in Estonian-speaking children aged 5–12 with ADHD or autism.
-
Social cognition testing for 8–16-year-olds with autism, ADHD, or atypical development
This project will test a multidimensional social-cognition battery in French-speaking 8–16-year-olds with autism, ADHD, or atypical neurodevelopment to see if it better identifies social processing differences.
-
Transcranial infrared light to the prefrontal cortex for adults with ADHD
This trial will try using transcranial infrared light on the prefrontal cortex to see if it improves attention, impulse control, and working memory in adults with ADHD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.